Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.34
-0.3500-0.36%
Volume:181.43K
Turnover:17.55M
Market Cap:24.20B
PE:-12.39
High:97.32
Open:97.24
Low:96.17
Close:96.69
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:108.00M
Volume Ratio:0.26
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.19
PE(LYR):-17.46

Loading ...

Earnings Flash (BNTX) BioNTech Posts Q2 Adjusted Loss 2.22 Euros a Share, vs. FactSet Est of 1.99 Euros Loss

MT Newswires Live
·
Aug 04

Stock Track | BioNTech Plunges 5.15% in Pre-market After Q2 Earnings Miss Estimates

Stock Track
·
Aug 04

BioNTech Q2 2026 Net Loss Widens to €820.8 Million; Revenue Drops 59.52% to €105.6 Million vs Q2 2025

Reuters
·
Aug 04

BioNTech Q2 Adj. EPS $(2.58) Misses $(2.34) Estimate, Sales $122.766M Miss $182.020M Estimate

Benzinga Earnings
·
Aug 04

Press Release: BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update

Dow Jones
·
Aug 04

Stocks to Watch: Palantir, SpaceX, HSBC

Dow Jones
·
Aug 04

BioNTech Names Ex-Sobi Chief Guido Oelkers as CEO, Succeeding Ugur Sahin

Reuters
·
Aug 03

Biontech SE Expected to Post a Loss of €2.09 a Share - Earnings Preview

Reuters
·
Jul 31

Sansure Biotech Gets Device Registration Certificate for COVID-19, Flu, RSV Detection Kits

MT Newswires Live
·
Jul 30

BioNTech (BNTX) Could Be 81% Undervalued After New Vaccine Patent Lawsuits

Simply Wall St.
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30

Earning Preview: BioNTech SE Q2 revenue is expected to increase by 6%, institutional views are leaning cautious

Earnings Agent
·
Jul 29

Pfizer (PFE) Faces New Patent Lawsuits Over Covid 19 Vaccine Technology

Simply Wall St.
·
Jul 23

Biontech to Report Q2 2026 Results, Host Investor Call

Reuters
·
Jul 21

Sunrise Names Andreas Tolpeit as New CFO to Drive Profitability and Strategy

TIPRANKS
·
Jul 20

BioNTech (BNTX) Faces Fresh Patent Lawsuits, Is The Valuation Gap Too Wide?

Simply Wall St.
·
Jul 19

How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines

Simply Wall St.
·
Jul 18

Arbutus Biopharma, Genevant sue Pfizer, BioNTech Over Lipid Nanoparticle Patents

MT Newswires Live
·
Jul 16